{"id":4728,"date":"2019-07-17T16:31:20","date_gmt":"2019-07-17T07:31:20","guid":{"rendered":"http:\/\/right23.cafe24.com\/en\/?p=4728"},"modified":"2023-09-18T10:05:10","modified_gmt":"2023-09-18T01:05:10","slug":"right-fund-announces-plan-to-invest-krw6-8b-in-public-health-projects-for-developing-countries-selected-for-1st-rfp-2","status":"publish","type":"post","link":"https:\/\/rightfoundation.kr\/en\/right-fund-announces-plan-to-invest-krw6-8b-in-public-health-projects-for-developing-countries-selected-for-1st-rfp-2\/","title":{"rendered":"RIGHT Fund Announces Plan to Invest KRW6.8B in Public Health Projects for Developing Countries Selected for 1st RFP"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4728\" class=\"elementor elementor-4728\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4e9b9f42 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4e9b9f42\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7cd17834\" data-id=\"7cd17834\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-644e80ea elementor-widget elementor-widget-stad_for_elementor_heading\" data-id=\"644e80ea\" data-element_type=\"widget\" data-widget_type=\"stad_for_elementor_heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\r\n\t<div class=\"stad-heading stad-heading-single-content stad-padding-0 stad-margin-0\">\t\t<span class=\"stad-heading-single-content-text stad-heading-content-text stad-inline-block\">\r\n\t\t\t\t\t\t\t<span class=\"stad-heading-single-content-text-content\">Selected were 4 projects by LG Chem, MMV, SD Biosensor, EuBiologics <br>\n\n2019 RIGHT Fund Investment Forum is held on 17th with 2nd RFP announced<\/span>\r\n\t\t\t\t\t<\/span>\r\n\t<\/div>\t\r\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2c9a4dc5 elementor-widget elementor-widget-text-editor\" data-id=\"2c9a4dc5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><strong>Seoul, Republic of Korea, July 17<sup>th<\/sup><\/strong>\u00a0<strong>2019<\/strong>\u00a0\u2013 The RIGHT Fund (Research Investment for Global Health Technology Fund, hereafter the RIGHT Fund, ) hosts the \u20182019 RIGHT Fund Investment Forum\u2019 on July 17<sup>th<\/sup>\u00a0in Seoul Korea. At the forum, The RIGHT Fund will announce the list of projects selected after the 1<sup>st<\/sup>\u00a0Request for Proposal (RFP) was released in Oct. last year as well as 2nd RFP plans.<\/p><p>The RIGHT Fund selected 4 projects for this year \u2013 two for vaccines, one for diagnostics, one for therapeutics \u2013 for an investment of around 6.8 billion won: optimization of production of hexavalent vaccine of existing DTwP-HepB-Hib vaccine plus IPV (Inactivated poliovirus vaccine, polio) by LG Chem; development of low cost, continuous-flow manufacturing process for ozonide-based antimalarials by Medicines for Malaria Venture (MMV) and SK Biotek; development of second generation test for identifying G6PD (Glucose-6-phosphate dehydrogenase) by SD Biosensor and PATH; and development of a cholera conjugate vaccine by EuBiologics, the International Vaccine Institute (IVI) and MGH-Harvard.<\/p><p>\u201cAfter the first RFP was released last October, and following and extensive two-tiered review process, four projects were selected for an award,\u201d said Younbeen Kim, CEO and Executive Director of The RIGHT Fund. \u201cI hope our investment can greatly accelerate these projects so that they can make a meaningful contribution powered by Korea\u2019s technical strength in the public health sector to enhance the public health equity in low-resourced countries.\u201d<\/p><p>During the forum\/, the RIGHT Fund also announces the 2<sup>nd<\/sup>\u00a0RFP, which focuses on R&amp;D initiatives for therapeutics, vaccines and diagnostics that can help prevent or alleviate infection with, progression of, and proliferation of endemic or new infectious disease in developing countries. The RIGHT Fund plans to select up to 10 projects in this 2<sup>nd<\/sup>\u00a0RFP and awardees to be announced in the first half of 2020. Applicants should submit their Intent to Apply by 10:00 am Sat. Aug. 17<sup>th<\/sup>(Korea Time), and more information can be found at the RIGHT Fund\u2019s website (<a href=\"https:\/\/rightfoundation.kr\/\">https:\/\/rightfoundation.kr<\/a>).<\/p><p>Founded in July 2018, The RIGHT Fund is a non-profit foundation established through the public-private partnership between the Ministry of Health and Welfare of South Korea, 5 Korean biopharmaceutical companies (SK bioscience, LG Chem, GC Pharma, Chong Kun Dang Pharm, Genexine) and the Bill and Melinda Gates Foundation with the mission of promoting global health. The RIGHT Fund selects R&amp;D projects leveraging Korean innovation and technology for the development of vaccines, therapeutics, and diagnostics that can address public health concerns and needs in developing countries with a total of 50 billion Korean won of investment planned by 2022.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-27534d98 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"27534d98\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-3077e0e9\" data-id=\"3077e0e9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-708f7842\" data-id=\"708f7842\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-72bae06a elementor-align-right elementor-mobile-align-left elementor-widget elementor-widget-button\" data-id=\"72bae06a\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a href=\"\/en\/press-releases\/\" class=\"elementor-button-link elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Press Release List<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Selected were 4 projects by LG Chem, MMV, SD Biosensor, EuBiologics 2019 RIGHT Fund Investment Forum is held on 17th with 2nd RFP announced Seoul, Republic of Korea, July 17th\u00a02019\u00a0\u2013 The RIGHT Fund (Research Investment for Global Health Technology Fund, hereafter the RIGHT Fund, ) hosts the \u20182019 RIGHT Fund Investment Forum\u2019 on July 17th\u00a0in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":3091,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"jetpack_featured_media_url":"https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2021\/07\/1-featured-img.jpg","_links":{"self":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/4728"}],"collection":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/comments?post=4728"}],"version-history":[{"count":11,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/4728\/revisions"}],"predecessor-version":[{"id":5941,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/4728\/revisions\/5941"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/media\/3091"}],"wp:attachment":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/media?parent=4728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/categories?post=4728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/tags?post=4728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}